North China Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

North China Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million ≈ $24.91 Million USD) by net assets (CN¥6.67 Billion ≈ $976.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of North China Pharmaceutical Co Ltd (1998–2025)

Cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2025. This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View North China Pharmaceutical Co Ltd share price for real-time trading data and today's change.

North China Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

North China Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 600812 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Porch Group Inc NASDAQ:PRCH	0.495x
VIEL & Cie société anonyme PA:VIL	0.110x
PT Sarana Menara JK:TOWR	0.152x
Supreme Electronics Co Ltd TW:8112	-0.817x
OCI Co Ltd KO:010060	0.034x
Deutsche EuroShop AG F:DEQ	0.023x
CHINA EAST ED HLDGS LTD F:ZX3	N/A
MBB INDUSTRIES XETRA:MBB	0.067x

Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2025. Review cash generation quality of North China Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.88 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $172.16 Million	0.171x	-7.24%
2024-12-31	CN¥6.67 Billion ≈ $976.71 Million	CN¥1.23 Billion ≈ $179.92 Million	0.184x	+12.77%
2023-12-31	CN¥6.27 Billion ≈ $917.56 Million	CN¥1.02 Billion ≈ $149.88 Million	0.163x	+1.30%
2022-12-31	CN¥6.23 Billion ≈ $911.41 Million	CN¥1.00 Billion ≈ $146.97 Million	0.161x	+7.75%
2021-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.05 Billion ≈ $153.68 Million	0.150x	+40.40%
2020-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥752.15 Million ≈ $110.06 Million	0.107x	-18.20%
2019-12-31	CN¥5.62 Billion ≈ $822.98 Million	CN¥732.97 Million ≈ $107.26 Million	0.130x	-7.23%
2018-12-31	CN¥5.51 Billion ≈ $806.58 Million	CN¥774.33 Million ≈ $113.31 Million	0.140x	+158.25%
2017-12-31	CN¥5.28 Billion ≈ $772.71 Million	CN¥287.25 Million ≈ $42.03 Million	0.054x	+164.46%
2016-12-31	CN¥5.29 Billion ≈ $774.28 Million	CN¥-446.53 Million ≈ $-65.34 Million	-0.084x	-463.04%
2015-12-31	CN¥5.27 Billion ≈ $771.13 Million	CN¥122.50 Million ≈ $17.92 Million	0.023x	+34.66%
2014-12-31	CN¥5.25 Billion ≈ $767.70 Million	CN¥90.56 Million ≈ $13.25 Million	0.017x	+153.00%
2013-12-31	CN¥4.15 Billion ≈ $606.67 Million	CN¥-135.03 Million ≈ $-19.76 Million	-0.033x	-112.90%
2012-12-31	CN¥4.18 Billion ≈ $611.39 Million	CN¥-63.92 Million ≈ $-9.35 Million	-0.015x	-108.83%
2011-12-31	CN¥1.31 Billion ≈ $192.27 Million	CN¥227.60 Million ≈ $33.30 Million	0.173x	+134.21%
2010-12-31	CN¥1.18 Billion ≈ $172.92 Million	CN¥-598.35 Million ≈ $-87.56 Million	-0.506x	-144.62%
2009-12-31	CN¥890.92 Million ≈ $130.37 Million	CN¥1.01 Billion ≈ $147.96 Million	1.135x	+74.64%
2008-12-31	CN¥1.67 Billion ≈ $244.43 Million	CN¥1.09 Billion ≈ $158.85 Million	0.650x	+42.40%
2007-12-31	CN¥1.46 Billion ≈ $213.02 Million	CN¥664.37 Million ≈ $97.22 Million	0.456x	+6.25%
2006-12-31	CN¥1.39 Billion ≈ $203.42 Million	CN¥597.12 Million ≈ $87.38 Million	0.430x	+179.39%
2005-12-31	CN¥1.46 Billion ≈ $213.37 Million	CN¥224.17 Million ≈ $32.80 Million	0.154x	-14.81%
2004-12-31	CN¥1.72 Billion ≈ $251.66 Million	CN¥310.39 Million ≈ $45.42 Million	0.180x	-14.31%
2003-12-31	CN¥2.76 Billion ≈ $403.19 Million	CN¥580.32 Million ≈ $84.92 Million	0.211x	-23.91%
2002-12-31	CN¥2.67 Billion ≈ $390.38 Million	CN¥738.50 Million ≈ $108.07 Million	0.277x	+103.57%
2001-12-31	CN¥2.70 Billion ≈ $395.23 Million	CN¥367.28 Million ≈ $53.74 Million	0.136x	+175.41%
2000-12-31	CN¥2.70 Billion ≈ $395.61 Million	CN¥133.49 Million ≈ $19.53 Million	0.049x	+135.17%
1999-12-31	CN¥2.66 Billion ≈ $389.44 Million	CN¥-373.62 Million ≈ $-54.67 Million	-0.140x	+17.86%
1998-12-31	CN¥1.91 Billion ≈ $279.75 Million	CN¥-326.74 Million ≈ $-47.81 Million	-0.171x	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.20 Billion

CN¥8.20 Billion CNY

Market Cap Rank

#7857 Global

#1733 in China

Share Price

CN¥4.78

Change (1 day)

-1.65%

52-Week Range

CN¥4.20 - CN¥6.63

All Time High

CN¥18.60